WHO panel advises against hydroxychloroquine use for COVID-19 |
Clinical News
eMediNexus Coverage from: 
WHO panel advises against hydroxychloroquine use for COVID-19

0 Read Comments                

A WHO expert panel has advised against the use of hydroxychloroquine for prevention of COVID-19 and has stated that the drug has no significant effect on patients who have already contracted the infection.

The agency’s Guideline Development Group (GDG) expert panel wrote in the BMJ that hydroxychloroquine should not be used in the fight against COVID-19. It further stated that it will not be beneficial to explore the drug in further research studies of possible COVID-19 treatments. As per experts, this “strong recommendation” comes after high-certainty evidence from six randomized controlled trials that included over 6,000 individuals, both with and without exposure to COVID-19… (Reuters, March 2, 2021)
To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now